Phase 3Recruiting
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Sponsored by Definium Therapeutics US, Inc.
About this study
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Enrolling at this location
Kadima Neuropsychiatry Institute
San Diego, California
I'm interestedThis study also enrolls at 33 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.